Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
State of the Facilities Management Industry in 2025
City of Hope to Open New Cancer Specialty Hospital in California
Montefiore Einstein Opening New Inpatient Center for Youth in the Bronx
Skill Stacking: How Micro-Credentials Are Reshaping Trades
Prima Medicine Opens New Location in Tysons, Virginia